The safety and effectiveness of remifentanil as an adjunct sedative for regional anesthesia

Citation
M. Lauwers et al., The safety and effectiveness of remifentanil as an adjunct sedative for regional anesthesia, ANESTH ANAL, 88(1), 1999, pp. 134-140
Citations number
25
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Journal title
ANESTHESIA AND ANALGESIA
ISSN journal
00032999 → ACNP
Volume
88
Issue
1
Year of publication
1999
Pages
134 - 140
Database
ISI
SICI code
0003-2999(199901)88:1<134:TSAEOR>2.0.ZU;2-S
Abstract
We assessed the sedative potential of continuous infusions of remifentanil with a validated composite alertness scale in 160 patients (ASA physical st atus I or Il) undergoing hip replacement surgery with spinal block (n = 61) or hand surgery using brachial plexus block (n = 93). They were randomized to receive one of the following initial dose regimens in double-blinded fa shion: placebo or 0.04, 0.07, or 0.1 mu g.kg(-1).min(-1) remifentanil subse quently titrated to effect. Additional midazolam IV was allowed for adequat e sedation as required. The combined analysis of both surgery groups reveal ed a dose-related increase in achievement of sedation level greater than or equal to 2 within 15 min of the start of the study drug infusion; all remi fentanil dose comparisons with placebo reached significance (P < 0.001). Th e remifentanil 50% effective dose for a composite sedation level greater th an or equal to 2 within 15 min of the start of drug infusion was estimated as 0.043 mu g.kg(-1).min(-1) (95% confidence interval 0.01, 0.059). The req uirement for midazolam decreased with increasing remifentanil dose compared with placebo (P < 0.001). The median time to return to alertness after the end of infusion was 10-12 min in the remifentanil groups and 5 min in the placebo group. Significant incidences of nausea, pruritus, sweating, and re spiratory depression were reported during remifentanil infusions compared w ith placebo. The data suggest that remifentanil may be useful for supplemen tation of regional anesthesia, provided that ventilation is carefully monit ored. Implications: In this dose-finding, placebo-controlled study, remifen tanil infusions were used to provide sedation during spinal and brachial pl exus regional anesthesia. The 50% effective dose for achievement of sedatio n was 0.043 mu g.kg(-1).min(-1). Return to alertness occurred after 10-12 m in (median time). Remifentanil infusions can be used to supplement regional anesthesia, but this requires careful monitoring of ventilation.